CSIMarket
 


Eyepoint Pharmaceuticals Inc   (EYPT)
Other Ticker:  
 

Cumulative Eyepoint Pharmaceuticals Inc 's Leverage Ratio for Trailing Twelve Months Period

EYPT's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

EYPT Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Growth -57.01 % -62.17 % -53.01 % -47.73 % 47.01 %
Y / Y Total Liabilities Growth 23.53 % 46.22 % -7.31 % 1.13 % 6.02 %
Leverage Ratio for Trailing Twelve Months Period 1.23 0.92 0.66 0.56 0.48
Total Ranking # 2106 # 1822 # 1457 # 1504 # 1283
Seq. Equity Growth 2.37 % -26.95 % -18.66 % -29.32 % -9.92 %
Seq. Total Liabilities Growth -14.79 % 60.24 % -9.64 % 0.13 % 0.86 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Despite debt repayement of -14.79% in III. Quarter, Leverage Ratio for Trailing Twelve Months Period improved to 1.23, below Eyepoint Pharmaceuticals Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Laboratory Analytical Instruments industry 21 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Eyepoint Pharmaceuticals Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are EYPT's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 22
Sector # 703
S&P 500 # 2370


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
7.19 1.45 0.27
(Sep 30 2020)   (June 30. 2015)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Laboratory Analytical Instruments Industry Leverage Ratio for Trailing Twelve Months Period
Kewaunee Scientific Corporation  2.16 
Bruker Corporation  1.83 
Pacific Biosciences Of California Inc   1.83 
Akoya Biosciences Inc   1.69 
Avantor Inc   1.54 
Isoplexis Corporation  1.12 
Eyepoint Pharmaceuticals Inc   1.05 
Harvard Bioscience Inc  0.96 
Perkinelmer Inc  0.92 
Agilent Technologies inc   0.92 
Revvity Inc   0.76 
Codex Dna Inc   0.70 
Phenomex Inc   0.55 
Illumina Inc   0.55 
Bio rad Laboratories Inc   0.41 
Lifeloc Technologies Inc   0.34 
Precipio inc   0.33 
Talis Biomedical Corporation  0.30 
Prenetics Global Limited  0.28 
Cue Health Inc   0.28 
Bionano Genomics Inc   0.25 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com